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Codling moth (CM, Cydia pomonella 
(Lepidoptera)) is a serious insect pest of 
apples, pears and walnut. Since many 
years, isolates of Cydia pomonella 
granulovirus (CpGV) are used as 
effective agents to control this pest. 
But in 2005, the first CM larvae, resistant 
to the commercial used virus CpGV-M 
(family Baculoviridae), were found and 
mean-while more than 40 orchards in 
Europe with CpGV resistance were iden-
tified.  
Further studies showed that there are 
three types of CpGV resistance. Type I 
resistance is inherited in a dominant and 
Z-chromosome linked way and directed
against CpGV-M, whereas the type II
resistance is dominant and autosomally
inherited. It is directed against CpGV-M
and CpGV-S. A third type has a mixed Z-
chromosomal and autosomal inheri-
tence.
There are only few CpGV isolates, such 
as CpGV-E2, which are able to break the 
different forms of resistance. Therefore, 
it is important, to search for other re-
sistance breaking Baculoviruses. Recent-
ly, a novel Alphabaculovirus CrpeSNPV, 
which was isolated from the litchi moth 
Cryptophlebia peltastica, had been 
shown to be effective against CM larvae. 
To test the efficacy of CrpeSNPV against 
resistant CM strains, full range bioassays 
were performed and the LC50 value was 
calculated. In addition, time mortality 
response was recorded to compare the 
speed of killing between CrpeSNPV and 
other CpGV isolates.  
Furthermore, experiments with the C. 
pomonella cell line Cp14R were con-
ducted to obtain more information 
about the in vitro replication capacity of 
this new Alphabaculovirus. 
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